Not Signed In -
Ramipril |
Altace |
Image:Ramipril.png Ramipril Systematic (IUPAC) name 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl) aminopropanoyl]- 4-azabicyclo[3.3.0] octane-3- carboxylic acid Identifiers CAS number 87333-19-5 ATC code C09AA05 PubChem 5362129 DrugBank APRD00009 Chemical data Formula C23H32N2O5 Mol. weight 416.511 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 2-4 hours Excretion ? Therapeutic considerations Pregnancy cat. D Legal ...
Wikipedia - [full article]
Ramipril Clinical Trials
- ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
Cardiovascular Diseases
- The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial
ClinicalTrials.gov Identifier: NCT00095654 - Active, not recruiting
Impaired Glucose Tolerance; Cardiovascular Disease; Glucose Metabolism Disorders
- The Study of Atherosclerosis with Ramipril and Rosiglitazone
ClinicalTrials.gov Identifier: NCT00140647 - Active, not recruiting
Atherosclerosis; Impaired Glucose Tolerance; isolated impaired fasting glucose; Cardiovascular Disease
- A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
ClinicalTrials.gov Identifier: NCT00368277 - Active, not recruiting
Hypertension
- Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00574834 - Recruiting
Metabolic Syndrome
- Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
ClinicalTrials.gov Identifier: NCT00366119 - Active, not recruiting
Essential Hypertension
- Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00343551 - Active, not recruiting
Essential Hypertension
- A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00389519 - Recruiting
Hypertension
- Comparison of Awakening vs. Bedtime Dosing of Ramipril in Subjects With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00473174 - Recruiting
Hypertension
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
ClinicalTrials.gov Identifier: NCT00208221 - Terminated
Hypertension; Type 2 Diabetes; Microalbuminuria
- Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina
ClinicalTrials.gov Identifier: NCT00507845 - Recruiting
Hypertension
- Irbesartan vs. Placebo in Combination with Ramipril for Treatment of Albuminuria
ClinicalTrials.gov Identifier: NCT00095290 - Completed
Albuminuria
- Prevention of Atherosclerosis and Heart Disease in Patients with Systemic Lupus Erythematosis (SLE)
ClinicalTrials.gov Identifier: NCT00054938 - Active, not recruiting
Systemic Lupus Erythematosus; Lupus
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
ClinicalTrials.gov Identifier: NCT00517322 - Recruiting
Left Atrial Volume; Hypertensive Heart Disease; Antihypertensive Drugs; Diastolic Function; Renin Angiotensin System
- Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
ClinicalTrials.gov Identifier: NCT00529451 - Recruiting
Hypertension
- RAAS, Inflammation, and Post-Operative Atrial Fibrillation - Specific Aim 3
ClinicalTrials.gov Identifier: NCT00141778 - Recruiting
Atrial Fibrillation
- Efficacy and Safety of Aliskiren +/- Ramipril When Added to Amlodipine in Hypertensive Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00542269 - Not yet recruiting
Hypertension With Metabolic Syndrome
- Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Renal Transplant Patients Converted to Sirolimus
ClinicalTrials.gov Identifier: NCT00502242 - Not yet recruiting
Kidney Transplant; Kidney Transplantation; Renal Transplant
- Safety and Effects of Ramipril Combined With Candesartan
ClinicalTrials.gov Identifier: NCT00356395 - Completed
Hypertension
- PRISMA = Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
ClinicalTrials.gov Identifier: NCT00274612 - Completed
Hypertension
- PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
ClinicalTrials.gov Identifier: NCT00274599 - Completed
Hypertension
- A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.
ClinicalTrials.gov Identifier: NCT00219089 - Completed
Hypertension, Diabetes Mellitus
- Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
ClinicalTrials.gov Identifier: NCT00281593 - Completed
Hypertension
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
ClinicalTrials.gov Identifier: NCT00355589 - Completed
Hypertension; Blood Pressure, High
- HYZAAR vs. Ramipril for Diabetes
ClinicalTrials.gov Identifier: NCT00480805 - Completed
Type 2 Diabetes Mellitus; Hypertension
- A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.
ClinicalTrials.gov Identifier: NCT00219063 - Completed
Hypertension.
- Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
ClinicalTrials.gov Identifier: NCT00367939 - Completed
Hypertension
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-Clinical Vasculopathy in Diabetes and IGT Patients
ClinicalTrials.gov Identifier: NCT00489229 - Completed
Diabetes; Impaired Glucose Tolerance
- Treatment of Pediatric Hypertension with Altace Trial
ClinicalTrials.gov Identifier: NCT00044265 - Completed
Hypertension
- Outcome Study ONTARGET
ClinicalTrials.gov Identifier: NCT00034931 - No longer recruiting
Coronary Disease; Angina Pectoris; Cerebrovascular Accident; Myocardial Infarction
- The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
ClinicalTrials.gov Identifier: NCT00168467 - Completed
Peripheral Arterial Disease
- Ramipril - Hypertension
ClinicalTrials.gov Identifier: NCT00325806 - Completed
Hypertension
- Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
ClinicalTrials.gov Identifier: NCT00005928 - Completed
Atherosclerosis; Coronary Disease; Vasculitis
- A Prospective, Randomized, Double-Blind, Double-Dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfun
ClinicalTrials.gov Identifier: NCT00240422 - Completed
Diabetes Mellitus, Type 2; Hypertension
- Angiotensin-II Blockade in Mitral Regurgitation
ClinicalTrials.gov Identifier: NCT00014846 - Completed
Heart Diseases; Mitral Valve Insufficiency
- Ramipril in Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00273533 - Completed
Arthritis, Rheumatoid
email this page
print this page
bookmark this page
feedback on this page
